Avient Corp (AVNT) 2025 Q4 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • Good morning, ladies and gentlemen, and welcome to Avient Corporation's webcast to discuss the company's fourth quarter and full-year 2025 results. My name is Michelle, and I'll be your operator for today. (Operator Instructions) As a reminder, this conference is being recorded for replay purposes.

    各位女士、先生,早安,歡迎收看 Avient Corporation 的網路直播,討論公司 2025 年第四季及全年業績。我叫 Michelle,今天將擔任您的電話會議接線員。(接線員指示) 提醒各位,本次會議將錄音以供回放。

  • I would now like to turn the call over to Joe Di Salvo, Vice President, Treasurer, Investor Relations. Please proceed.

    現在我想將電話會議交給 Joe Di Salvo,副總裁、財務主管暨投資人關係負責人。請開始。

  • Giuseppe Di Salvo - Vice President, Treasurer, Investor Relations

    Giuseppe Di Salvo - Vice President, Treasurer, Investor Relations

  • Thank you, and good morning, everyone, joining us on the call today. Before we begin, we'd like to remind you that statements made during this webcast may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

    謝謝,各位早安,感謝今天加入電話會議的各位。在開始之前,我們提醒您,本次網路直播中所作的陳述,可能構成 1995 年《私人證券訴訟改革法》所定義的前瞻性陳述。

  • Forward-looking statements will give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectation and involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. We encourage you to review our most recent reports, including our 10-K or any applicable amendments, for a complete discussion of these factors and other risks that may affect our future results.

    前瞻性陳述反映對未來事件的當前預期或預測,並非對未來績效的保證。其係基於管理階層的預期,並涉及多項商業風險與不確定性,其中任何一項都可能導致實際結果與前瞻性陳述中明示或暗示的內容存在重大差異。我們鼓勵您查閱我們最新的報告(包括 10-K 或任何適用的修訂),以完整了解這些因素以及其他可能影響我們未來業績的風險。

  • During the discussion today, the company will use both GAAP and non-GAAP financial measures. Please refer to the presentation posted on the Investor Relations section of the Avient website where the company describes the non-GAAP measures and provides a reconciliation of historical non-GAAP financial measures to their most directly comparable GAAP financial measures. A replay of this call will be available on our website. Information to access the replay is listed in today's press release, which is available at avient.com in the Investor Relations section.

    在今天的討論中,公司將同時使用 GAAP 與非 GAAP 財務衡量指標。請參閱 Avient 網站投資人關係專區所發布的簡報,其中公司說明非 GAAP 指標,並提供歷史非 GAAP 財務指標與其最直接可比的 GAAP 財務指標之調節表。本次電話會議的回放將於我們網站提供。回放的存取資訊列於今日新聞稿中,新聞稿可於 avient.com 的投資人關係專區取得。

  • Joining me on the call today is our Chairman, President, and Chief Executive Officer, Dr. Ashish Khandpur; and Senior Vice President and Chief Financial Officer, Jamie Beggs.

    今天與我一同參與電話會議的有:董事長、總裁暨執行長 Ashish Khandpur 博士;以及資深副總裁暨財務長 Jamie Beggs。

  • I will now hand the call over to Ashish to begin.

    現在我將把電話會議交給 Ashish 開始。

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Thank you, Joe, and good morning, everyone. Strong execution by our teams with favorable mix and management's tight cost control led to 80 basis points of adjusted EBITDA margin expansion and a strong 14% adjusted EPS growth for the fourth quarter. With this result, we expanded our adjusted EBITDA margins year over year in each of the four quarters of 2025. Organic sales in Q4 were down slightly at 0.8% and grew 1.9% as reported over the prior year due to favorable foreign exchange impact.

    謝謝你,Joe,各位早安。我們團隊強勁的執行力,加上有利的產品組合,以及管理階層嚴格的成本控管,使第四季調整後 EBITDA 利潤率擴張 80 個基點,調整後 EPS 亦強勁成長 14%。憑藉此一成果,我們在 2025 年四個季度皆實現調整後 EBITDA 利潤率的年對年擴張。第四季有機銷售小幅下滑 0.8%;受惠於有利的外匯影響,按報告口徑較去年成長 1.9%。

  • As we had highlighted in our third-quarter's earnings call, we continue to see strong momentum in defense, health care, and telecom markets with business growing double digits in each. In addition, packaging demand improved modestly, growing sales low single digits in the fourth quarter compared to being down low single digits in the third quarter. As expected, businesses in our other markets finished down versus the prior year.

    如同我們在第三季法說會中所強調的,我們在國防、醫療保健與電信市場持續看到強勁動能,三者業務皆呈雙位數成長。此外,包裝需求小幅改善,第四季銷售呈低個位數成長,相較第三季為低個位數下滑。如預期,我們其他市場的業務相較去年呈現下滑。

  • Moving to the right-hand side of the slide. For the full-year 2025, sales were relatively flat year over year. Favorable product mix and our productivity initiatives led to 50 basis points of adjusted EBITDA margin expansion versus 2024, helping us achieve full-year record high margins of 16.7%. Adjusted EBITDA finished at $545 million for 2025 with 3.5% year-over-year growth as reported. Adjusted EPS grew 6%, helped by lower interest expense and favorable foreign currencies.

    接著看投影片右側。2025 全年銷售額年對年大致持平。有利的產品組合與我們的生產力提升計畫,使調整後 EBITDA 利潤率較 2024 年擴張 50 個基點,協助我們達成全年創新高的 16.7% 利潤率。2025 年調整後 EBITDA 為 5.45 億美元,按報告口徑年對年成長 3.5%。受惠於較低的利息費用與有利的外幣因素,調整後 EPS 成長 6%。

  • Our team's highly disciplined cash management helped us generate $195 million of free cash flow, enabling us to reduce our outstanding debt by $150 million and end the year with a net leverage ratio of 2.6x. As you know, one of our key drivers to advance our strategy is innovation. Creating meaningful and differentiated products, especially in markets supported by secular trends, will not only help us grow faster, but also increase our profitability.

    我們團隊高度自律的現金管理,協助我們創造 1.95 億美元自由現金流,使我們得以將未償債務減少 1.5 億美元,並以 2.6 倍的淨槓桿比率結束年度。各位知道,推進我們策略的關鍵驅動力之一是創新。打造具意義且差異化的產品,特別是在受長期結構性趨勢支持的市場中,不僅能幫助我們更快成長,也能提升獲利能力。

  • Today, I would like to share some examples of recent innovations from our company. The first set of examples address the need and demand for non-PFAS products in applications currently using PFAS materials, which are facing stringent regulations, especially in the United States and Europe.

    今天,我想分享公司近期創新的一些例子。第一組例子聚焦於在目前使用 PFAS 材料、且面臨嚴格法規(尤其在美國與歐洲)的應用中,對非 PFAS 產品的需求與市場需求。

  • Our teams recently developed and commercialized GlideTech technology, which enables new non-PFAS and non-silicon lubricious materials for use in catheters, particularly those used in neurological and vascular applications. Our portfolio contains formulations that are ISO 10993-5 and USP 87 compliant in standard grades. These products deliver exceptional coefficient of friction reduction, are compatible with all common sterilization methods, and processable using conventional extrusion equipment.

    我們團隊近期開發並商業化 GlideTech 技術,使導管(特別是用於神經與血管應用者)可採用新的非 PFAS、非矽的潤滑材料。我們的產品組合包含符合 ISO 10993-5 與 USP 87 的標準等級配方。這些產品可顯著降低摩擦係數,與所有常見滅菌方式相容,並可使用傳統擠出設備加工。

  • Another example in this space is non-PFAS polymer processing aids for polyolefin film used in packaging applications for personal care products. Here, we have innovated and launched a portfolio of products in 2025, and several other customer manufacturing qualifications are in progress currently.

    在此領域的另一個例子,是用於個人護理產品包裝應用之聚烯烴薄膜的非 PFAS 聚合物加工助劑。在此方面,我們已於 2025 年創新並推出一系列產品組合,目前亦有多項其他客戶的製造資格認證正在進行中。

  • We continue to gain more knowledge and experience in this new area, working closely with our customers and understanding the interplay between our innovative materials and their processes. The last example for today is a process innovation, where we can unlock additional Dyneema fiber making capacity with tailored material properties using our existing manufacturing equipment. As you may recall, demand for our products in defense grew double digits in 2024, followed by high single-digit growth in 2025. We expect this momentum to continue, supported by the announced increases in defense spending over the next few years, especially in the United States and Europe.

    我們持續在這個新領域累積更多知識與經驗,與客戶緊密合作,並理解我們創新材料與其製程之間的相互作用。今天最後一個例子是製程創新:我們可利用既有製造設備,在具備客製化材料特性的前提下,釋放額外的 Dyneema 纖維製造產能。如各位所記得,我們國防產品需求在 2024 年呈雙位數成長,2025 年則續以高個位數成長。我們預期在未來幾年已宣布的國防支出增加(尤其在美國與歐洲)的支持下,這股動能將持續。

  • Due to the success of our innovation, we will now be able to quickly unlock meaningful new capacity from our current manufacturing lines to support the anticipated growth in our defense growth vector. In addition, we plan to deploy incremental capital over the next two years to further expand capacity and support the growth we foresee from our Dyneema-based businesses. Jamie will share more about these investments in her section.

    由於我們創新的成功,我們現在將能迅速從現有製造產線釋放具規模的新產能,以支援我們在國防成長向量中預期的成長。此外,我們計畫在未來兩年投入額外資本,進一步擴充產能,並支援我們預見 Dyneema 相關業務的成長。Jamie 將在她的段落中分享更多關於這些投資的內容。

  • Before we get to 2026, I would like to take a moment to reflect on our performance over the last two years. As you know, in 2024, we evolved our company strategy to prioritize organic growth to be complemented by targeted M&A where it enhances our capabilities. We also sharpened our focus on profitability to deliver both top-line growth and margin expansion. 2023 to 2025 marked the first period of time in nearly 20 years where there has been no impact on financials from acquisitions or divestitures, providing clean and noise-free data to compare performance.

    在談到 2026 年之前,我想先花一點時間回顧我們過去兩年的表現。如各位所知,2024 年我們調整公司策略,優先推動有機成長,並以能強化我們能力的目標式併購作為補充。我們也更聚焦於獲利能力,以同時實現營收成長與利潤率擴張。2023 至 2025 年是近 20 年來首次在財務表現上未受併購或資產剝離影響的期間,提供更乾淨、無雜訊的數據以比較績效。

  • I'm happy to report that over the last two years, our strategy has gained significant traction with our prioritized growth vectors delivering substantial growth with innovation beginning to show up in differentiated products and improved margins. Additionally, we continue to eliminate structural complexity and drive productivity to become a more agile and customer-focused organization. These actions have enabled us to deliver consistent improvements across our key financial metrics for the second consecutive year despite a volatile macro backdrop.

    我很高興報告,在過去兩年中,我們的策略已獲得顯著進展,我們優先的成長向量帶來了可觀的成長,創新也開始體現在差異化產品與改善的利潤率上。此外,我們持續消除結構性複雜度並推動生產力提升,以成為更敏捷且以客戶為中心的組織。儘管宏觀環境波動,我們仍連續第二年在關鍵財務指標上實現一致性的改善。

  • Over the last two years, we have grown adjusted earnings per share by about 20% and expanded adjusted EBITDA margins by 70 basis points, 20 basis points in 2024 and an additional 50 basis points in 2025. As a result, ROIC has improved each year and is now up 90 basis points versus 2023.

    在過去兩年中,我們的調整後每股盈餘約成長20%,調整後EBITDA利潤率擴張70個基點,其中2024年擴張20個基點,2025年再額外擴張50個基點。因此,ROIC每年皆有所改善,且相較於2023年目前提升了90個基點。

  • Our strong free cash flow generation and disciplined capital deployment also allowed us to reduce debt, bringing net leverage down from 3.1x in 2023 to 2.6x in 2025. Importantly, we achieved these results while continuing to invest in the business, particularly in our prioritized growth vectors aligned with our strategy. As we move forward, we plan to continue advancing these value creation metrics as we have over the past eight quarters. With increasing traction from our growth vectors and innovation pipeline, we expect to scale revenue and margin expansion with greater ease over time.

    我們強勁的自由現金流創造能力與嚴謹的資本配置,也使我們得以降低負債,將淨槓桿由2023年的3.1倍降至2025年的2.6倍。重要的是,我們在達成這些成果的同時仍持續投資於業務,特別是投資於與我們策略一致的優先成長向量。展望未來,我們計畫延續過去八個季度的作法,持續推進這些價值創造指標。隨著成長向量與創新管線的動能提升,我們預期隨時間推移,營收規模化與利潤率擴張將更為順暢。

  • Coming specifically to 2026, our premise is that macro environment will remain volatile, impacted by trade policies, geopolitics, and moving supply chains. However, we are cautiously optimistic about 2026 being a better year than 2025 from a market demand perspective. This is especially true for our Color, Additives, and Inks, or CAI business, which showed negative 2% organic growth in 2025.

    具體談到2026年,我們的前提是宏觀環境仍將維持波動,並受到貿易政策、地緣政治以及供應鏈移轉的影響。然而,從市場需求角度來看,我們對2026年將優於2025年抱持審慎樂觀。這對我們的色彩、添加劑與油墨(Color, Additives, and Inks,CAI)業務尤其如此,該業務在2025年的有機成長為負2%。

  • Last year, some of the biggest markets for the CAI business, namely consumer, industrial, building and construction, and transportation saw anemic demand, while packaging was relatively flat. With 2026 showing stronger than 2025 US GDP growth projections and several government initiatives in the United States like the new tax bill, focus on domestic manufacturing expansion, and the potential for easing interest rates, demand in our relevant markets is expected to improve. This would be a welcome scenario for our customers and our business. But at the same time, we are also focused on driving productivity in the organization to ensure we continue to drive our earnings and margin expansion in case market demand does not improve.

    去年,CAI業務的一些最大市場——包括消費、工業、建築與營建以及運輸——需求疲弱,而包裝則相對持平。隨著2026年美國GDP成長預測高於2025年,以及美國多項政府倡議(如新的稅收法案、聚焦擴大國內製造,以及利率可能趨於下調),我們相關市場的需求預期將改善。這將是對我們客戶與我們業務都樂見的情境。但同時,我們也專注於推動組織生產力,以確保即使市場需求未改善,我們仍能持續推動獲利與利潤率擴張。

  • We grew our Specialty Engineered Materials segment sales by 2% in 2025, excluding foreign currency impact, and we believe there are several secular macro trends in this business that will support organic sales growth again this year.

    2025年我們的特種工程材料(Specialty Engineered Materials)部門銷售額(排除外匯影響)成長2%,我們相信該業務存在數項長期結構性宏觀趨勢,將在今年再次支持有機銷售成長。

  • Before I hand the call over to Jamie, who will provide additional color on our 2025 segment and regional performance as well as our guidance for 2026, I would like to thank the entire Avient team for their determination and outstanding efforts to successfully deliver in 2025. I have no doubt our team is up to the task to deliver an even stronger 2026. Jamie?

    在我把電話交給Jamie之前——他將就我們2025年的部門與區域表現,以及2026年的指引提供更多說明——我想感謝整個Avient團隊的決心與卓越努力,成功交出2025年的成果。我毫不懷疑,我們的團隊有能力在2026年交出更強勁的表現。Jamie?

  • Jamie Beggs - Chief Financial Officer, Senior Vice President

    Jamie Beggs - Chief Financial Officer, Senior Vice President

  • Thank you, Ashish, and good morning, everyone. I'll start with the fourth-quarter performance of our Color, Additives, and Inks segment. Continued strength in health care and improving packaging demand was not enough to offset demand conditions in consumer, industrial, and building and construction, which led to a 3% decline in organic sales for the segment during the quarter. EBITDA margins declined 10 basis points as productivity initiatives helped mitigate the impact of inflation and reduced demand. Specialty Engineered Materials organic sales increased 3% as strong growth in defense, health care, and telecommunications more than offset lower sales in energy, industrial, and building and construction end markets.

    謝謝你,Ashish,各位早安。我先從我們色彩、添加劑與油墨部門的第四季表現談起。醫療保健的持續強勁與包裝需求改善,仍不足以抵消消費、工業以及建築與營建領域的需求狀況,導致該部門本季有機銷售下滑3%。EBITDA利潤率下滑10個基點,生產力措施有助於緩解通膨與需求下滑的影響。特種工程材料的有機銷售成長3%,國防、醫療保健與電信的強勁成長,足以抵消能源、工業以及建築與營建終端市場的較低銷售。

  • Healthcare continues to deliver strong growth, supported by our innovative and specified materials for use in medical devices, equipment, and supplies. Defense grew double digits in the quarter, driven by strong US and European demand and supported by new innovation, including next-generation materials in our Dyneema line that we've highlighted in the past. Favorable mix and productivity contributed to 80 basis points of margin expansion, which combined with higher demand and positive FX resulted in 10% EBITDA growth.

    醫療保健持續帶來強勁成長,受惠於我們用於醫療器材、設備與耗材的創新且具規格要求的材料。國防在本季呈現雙位數成長,受強勁的美國與歐洲需求帶動,並由新創新所支撐,包括我們先前提及的Dyneema產品線中的下一代材料。有利的產品組合與生產力帶來80個基點的利潤率擴張,並與較高需求及正向外匯影響相結合,使EBITDA成長10%。

  • In the fourth quarter, US/Canada sales declined 1%, which is an improvement from the prior quarter's 5% year-over-year decline as we saw positive growth in packaging. This, combined with continued underlying strength in health care, defense, and telecom demand, partially offset lower sales in the industrial, building and construction, and energy markets. Future policy changes and lower inflation could be positive factors that provide momentum to the region in 2026.

    第四季,美國/加拿大銷售下滑1%,較前一季年減5%有所改善,因我們在包裝領域看到正成長。這一點,加上醫療保健、國防與電信需求的持續基本面強勁,部分抵消了工業、建築與營建以及能源市場的較低銷售。未來政策變化與較低通膨,可能成為在2026年為該區域提供動能的正面因素。

  • Similar to the US/Canada, EMEA also performed slightly better than the third quarter, where organic sales only declined 2% on a year-over-year basis. Positive growth in the consumer end market, primarily driven by an increase in small and large appliances, along with continued momentum for defense and health care helped offset weaker industrial demand.

    與美國/加拿大類似,EMEA的表現也較第三季略有改善,當時有機銷售年減僅2%。消費終端市場的正成長(主要由小型與大型家電增加所帶動),以及國防與醫療保健的持續動能,有助於抵消較疲弱的工業需求。

  • Asia grew 3%, driven by strength in packaging and telecommunications. The secular trend of high-performance computing is creating new opportunities for our materials. This has helped offset weak consumer demand, particularly in textile applications. Latin America sales declined 5%, primarily due to softer consumer demand and a difficult year-over-year comparison where the region grew 14% in the fourth quarter last year.

    亞洲成長3%,由包裝與電信的強勁表現帶動。高效能運算的長期趨勢正為我們的材料創造新機會。這有助於抵消疲弱的消費需求,尤其是在紡織應用方面。拉丁美洲銷售下滑5%,主要因消費需求轉弱,以及去年第四季該區域成長14%所造成的較高比較基期。

  • Turning to full-year 2025 results. We navigated an uncertain macro environment while delivering bottom-line growth through customer focus, innovation, productivity, and operational discipline. Full-year CAI organic sales declined 2%. Steady growth in health care throughout 2025 helped offset softer demand in consumer, industrial, transportation, and building and construction. Packaging remained relatively resilient, ending the year flat versus 2024.

    接著看2025年全年結果。我們在不確定的宏觀環境中前行,同時透過聚焦客戶、創新、生產力與營運紀律,實現獲利端成長。CAI全年有機銷售下滑2%。2025年醫療保健的穩健成長,有助於抵消消費、工業、運輸以及建築與營建需求的走弱。包裝相對具韌性,全年結束時與2024年相比持平。

  • EBITDA margins expanded 50 basis points, benefiting from favorable mix and productivity tied to our plant footprint optimization as well as initiatives to streamline the organization, allowing us to serve our customers more efficiently. SEM organic sales grew 2%, driven by defense, health care, and telecommunications, partially offset by subdued consumer, industrial, and energy demand.

    EBITDA利潤率擴張50個基點,受惠於有利的產品組合,以及與我們工廠版圖優化相關的生產力提升,並加上精簡組織的措施,使我們能更有效率地服務客戶。SEM有機銷售成長2%,由國防、醫療保健與電信帶動,部分被消費、工業與能源需求低迷所抵消。

  • EBITDA margins declined 40 basis points, primarily reflecting planned maintenance in our Avient Protective Materials business completed in the second quarter of 2025 and strategic investments in our growth vectors in this business.

    EBITDA利潤率下滑40個基點,主要反映我們Avient防護材料(Protective Materials)業務在2025年第二季完成的計畫性維護,以及在該業務成長向量上的策略性投資。

  • Turning to our 2026 outlook. Our full-year guidance reflects a balance between encouraging demand trends across our portfolio and continued macro uncertainty and volatility. As Ashish mentioned in his comments, we are cautiously optimistic that some of our end markets negatively impacted in 2025 will start to improve in the coming year, including consumer, industrial, and building and construction.

    接著談我們對 2026 年的展望。我們的全年指引反映了在投資組合各項業務令人鼓舞的需求趨勢與持續的總體經濟不確定性及波動之間取得平衡。如 Ashish 在評論中提到的,我們謹慎樂觀地認為,部分在 2025 年受到負面影響的終端市場將在來年開始改善,包括消費、工業,以及建築與營建。

  • Favorable government policies and easing interest rates, as an example, could spur consumer and housing demand as we progress through the upcoming year. With that being said, uncertainty remains with evolving global trade, labor market, GDP growth rates, and foreign currency fluctuations.

    例如,有利的政府政策與利率下行,可能在接下來一年推動消費與住宅需求。儘管如此,隨著全球貿易演變、勞動市場、GDP 成長率以及外匯波動,不確定性仍然存在。

  • Accordingly, we are establishing full-year guidance for adjusted EBITDA of $555 million to $585 million, which is up 2% to 7% year over year as well as adjusted EPS of $2.93 to $3.17, which is up 4% to 12% over the prior year. This range includes our first-quarter adjusted EPS outlook of $0.81. Productivity will again play a role in supporting earnings growth and margin expansion in 2026.

    因此,我們設定全年調整後 EBITDA 指引為 5.55 億至 5.85 億美元,年增 2% 至 7%;調整後 EPS 指引為 2.93 至 3.17 美元,較前一年成長 4% 至 12%。此區間包含我們第一季調整後 EPS 展望 0.81 美元。生產力將在 2026 年再次扮演支撐獲利成長與毛利率擴張的角色。

  • We will see carryover benefits from initiatives executed in 2025, along with new actions that are now underway. In addition, we will monitor demand conditions and are prepared to enact additional actions should the demand environment not improve.

    我們將看到 2025 年已執行之措施所帶來的延續效益,以及目前正在推進的新行動。此外,我們將監測需求狀況,若需求環境未改善,我們也已準備好採取額外行動。

  • Regarding free cash flow, we expect another strong year of cash generation with an anticipated range of $200 million to $220 million for the full year. This assumes capital expenditures of $140 million, which is approximately $33 million more than 2025. This is driven primarily by the incremental investments to support growth in our defense business, as Ashish highlighted earlier today.

    就自由現金流而言,我們預期全年仍將有強勁的現金創造,全年預估區間為 2.00 億至 2.20 億美元。此假設資本支出為 1.40 億美元,約較 2025 年多 3,300 萬美元。這主要是由於為支持國防業務成長而增加的投資,正如 Ashish 今天稍早所強調。

  • As we demonstrated in 2024 and 2025, we have consistently moved the key value creation metrics in the right direction even in a tough macro environment. Our guidance for 2026 projects another year of adjusted EPS and adjusted EBITDA growth, improved return on invested capital, and a reduction in net leverage. Our strategy of catalyzing the core and building platforms of scale continues to bear fruit and create value for our shareholders.

    如同我們在 2024 年與 2025 年所展現的,即便在艱困的總體環境下,我們仍持續將關鍵價值創造指標朝正確方向推進。我們對 2026 年的指引預期調整後 EPS 與調整後 EBITDA 將再成長一年、投入資本報酬率提升,並降低淨槓桿。我們「催化核心、打造規模化平台」的策略持續開花結果,並為股東創造價值。

  • With that, we will now open the line for Q&A.

    接下來,我們開放問答。

  • Operator

    Operator

  • (Operator Instructions) Michael Sison, Wells Fargo.

    (接線員指示) Wells Fargo 的 Michael Sison。

  • Michael Sison - Analyst

    Michael Sison - Analyst

  • Nice quarter and nice finish for the year. Ashish, you sort of mentioned that some of these markets will improve or could potentially improve this year. Are you seeing any sort of green shoots in some of those, the consumer, industrial, transportation, and construction areas now? And then at the midpoint of your guidance, what type of improvement would you need to get to hit it?

    本季表現不錯,全年收官也很漂亮。Ashish,你提到其中一些市場今年將改善或可能改善。你現在是否在消費、工業、運輸以及建築與營建等領域看到任何回溫跡象?另外,以你們指引的中位數來看,要達到該水準需要什麼樣的改善幅度?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Thanks, Mike, for the question. So part of the improvement that we are seeing in US, especially, we expect in Q1 for consumer and packaging to flip from negative to positive. Last year, packaging Q1 was pretty negative, down 10% in US. And so the comps are pretty favorable, and so that's going to help us. But in general, we are seeing better conditions than we were seeing before on the packaging side. As you saw that in Q4 itself, packaging was up 1% in the United States. So that's a good sign.

    謝謝你,Mike,謝謝提問。我們看到的改善之一,特別是在美國,我們預期第一季消費與包裝將由負轉正。去年第一季包裝在美國相當疲弱,下滑 10%。因此比較基期相當有利,這會對我們有幫助。但整體而言,在包裝端我們看到的狀況比之前更好。如你在第四季所見,包裝在美國成長 1%。這是個好訊號。

  • On the consumer side, it's still subdued, but probably getting a little bit better. Too early to say. There is a little bit noise in the system with the Asia situation with the Chinese New Year moving overall. And so we generally don't want to make too many assumptions with respect to January itself because there might be some pull-ins from February based on the China New Year situation. And so we'd like to see January and February together on that one.

    在消費端仍偏疲弱,但可能正在稍微好轉。現在下結論還太早。由於亞洲情勢、以及農曆新年時間整體移動,系統中有一些雜訊。因此我們一般不想對 1 月單月做太多假設,因為基於中國農曆新年的因素,可能會有一些原本 2 月的需求提前到 1 月。所以我們希望把 1 月與 2 月一起看。

  • But overall, January came a little marginally better, I would say, definitely as well as we expected, marginally better. So that gives us some optimism at this point in time. But as I said, we are not reading too much into it because there might be a little bit noise in the data from Asia. But overall, I think we are feeling that consumer and packaging should be at least turning positive in the first half of the year for sure and for United States, probably in first quarter.

    但整體來看,我會說 1 月略微好一些,至少符合我們預期,甚至略優於預期。因此在此刻給了我們一些樂觀的理由。但如我所說,我們不會過度解讀,因為資料中可能有一些來自亞洲的雜訊。不過整體而言,我認為我們感覺消費與包裝至少在上半年應該會轉正;就美國而言,可能在第一季就會轉正。

  • And then the other part of the question is on the guidance on midpoint. So on the low end of the range, we kind of expect that the consumer, industrial, and the building and construction markets will probably not improve. They stay as they are. In the midpoint, that assumes that there is a modest growth in all of there, probably low single-digit kind of growth, and packaging also a little bit more modest growth.

    至於你問題的另一部分,關於指引的中位數。在區間低端,我們大致假設消費、工業以及建築與營建市場可能不會改善。它們維持現狀。在中位數情境下,則假設上述各市場都有溫和成長,可能是低個位數成長,而包裝也會有更溫和的成長。

  • And then on the high end of the range is a little bit more robust growth. So what typically we would grow in a good year. So that's probably the range, and that captures our EBITDA ranges and our sales range and everything.

    而在區間高端,則是更為強勁的成長。也就是我們在景氣好的一年通常會達到的成長。大致就是這樣的範圍,並涵蓋我們的 EBITDA 區間、銷售區間以及其他各項。

  • Michael Sison - Analyst

    Michael Sison - Analyst

  • Got it. And then a quick follow-up. When you think about the last two years, you spent a lot of time on innovation, R&D and trying to get your growth vectors to sort of get beefed up. So when you think about 2026, how much growth do you think you'll generate from those initiatives? And are there any particular product lines or end markets that is going to drive that?

    了解。再快速追問一下。回顧過去兩年,你們在創新、研發上投入很多時間,並試圖強化你們的成長動能。那麼展望 2026 年,你認為這些計畫能帶來多少成長?是否有任何特定產品線或終端市場會驅動這些成長?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes. So we've been trying to highlight some of our innovation in multiple earnings calls like these. And to get today, again, I highlighted a few new ones that did not exist a couple of years ago, so to say. So the idea is to tell the audience that, hey, we are moving ahead on this. Our intellectual property filings, for example, last two years, we've filed 50-plus patents, which includes initial patent filings, provisional patents as well as [PCT] filings. So that's 50-plus for both the years. And that compares to a number of 20-odd maybe a couple or two or three years ago. So you can see how much innovation is going on. That's an indirect measure.

    是的。我們一直嘗試在像這樣的多次法說會中強調我們的一些創新成果。而今天我也再次提到幾項新的內容,可以說在幾年前並不存在。目的就是要讓聽眾知道:我們正在持續推進。例如在智慧財產權申請方面,過去兩年我們申請了 50 件以上的專利,包含初始專利申請、臨時專利以及 [PCT] 申請。所以兩年合計是 50 件以上。相較之下,兩三年前可能只有約 20 件左右。因此你可以看到創新活動有多活躍。這是一個間接指標。

  • From a financial perspective, if you take 2025, our growth vectors grew high single digits. So almost closer to 10% versus closer to 5%, I would say. And the rest of the businesses actually did not grow. And that gives you an idea of what's -- why we were still flat in a year that was so much demand where the demand was so low in most of our core markets. And the big idea is that, hey, with these growth vectors, we are really now trying to build businesses of scale in markets that are supported by secular trends and growing at rates much faster than GDP. And that seems to be taking hold. So maybe that's where I'll leave it.

    從財務角度來看,如果以 2025 年為例,我們的成長動能業務達到高個位數成長。也就是說,我會說更接近 10%,而不是接近 5%。而其餘業務實際上並沒有成長。這也讓你理解為什麼——在我們多數核心市場需求非常疲弱的一年裡,我們整體仍能維持持平。核心概念是:透過這些成長動能,我們正努力在受長期結構性趨勢支持、且成長速度遠高於 GDP 的市場中,打造具規模的業務。而這似乎正在逐步成形。我大概就先說到這裡。

  • Operator

    Operator

  • Laurence Alexander, Jefferies.

    Laurence Alexander,Jefferies。

  • Daniel Rizzo - Analyst

    Daniel Rizzo - Analyst

  • It's Dan Rizzo, on for Laurence. You kind of went through some end markets, but maybe I missed it, but you didn't mention transportation and the outlook for that. I don't know if I missed it, but what are we thinking there? Is it expected to improve at all?

    我是 Dan Rizzo,代替 Laurence。你大致談到了一些終端市場,但也許我漏聽了,你沒有提到運輸(transportation)以及那方面的展望。我不知道是不是我漏掉了,但我們對那邊的看法是什麼?預期會有任何改善嗎?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes. So transportation for us, Laurence (sic - Dan) was overall down minus 1% for the year. And it's a little bit of a regional story. We grew in EMEA plus 1% versus the auto build was like minus 1%, and we grew in Asia 5%, which was consistent with the builds in the Asia market. In United States, the market was down minus 1% for the year, but we were down minus 5%.

    是的。所以對我們而言,Laurence(口誤—Dan),運輸業務全年整體下滑 1%。而且這有點是區域性的故事。我們在 EMEA 成長 1%,而汽車產量大概是下滑 1%;我們在亞洲成長 5%,與亞洲市場的產量變化一致。在美國,市場全年下滑 1%,但我們下滑了 5%。

  • And that's largely driven by the fact that we also have rail and commercial vehicles in our transportation, which were down significantly in the United States. So in the auto business, we are doing fine with how the markets are doing, but the rail and the commercial vehicle piece brought us down a little bit.

    這主要是因為我們的運輸業務也包含鐵路與商用車,而這兩塊在美國下滑得很明顯。所以在汽車業務方面,我們跟著市場表現其實還不錯,但鐵路與商用車這一塊讓我們整體被拉低了一些。

  • As I look into the future, I think we are not -- we are watching transportation carefully. There was a lot of build that happened towards the end of the last year in China, especially because of their structural reform that they are -- they call it supply side structural reform where they were going to put restrictions on export of EV vehicles starting January 1. So a lot of material got pushed out at the end of the year, which we benefited from. And as I said, we grew 5% in Asia. But I think Q1 probably will be softer based on that. And then for the total year, flattish to low single digit is my projection.

    展望未來,我認為我們會——我們正在密切關注運輸領域。去年年底中國有一波大量的產量拉升,特別是因為他們的結構性改革——他們稱之為供給側結構性改革——原本要從 1 月 1 日起對電動車出口施加限制。因此很多材料在年底被提前出貨,我們也因此受惠。如我所說,我們在亞洲成長了 5%。但我認為第一季可能會因為這個因素而偏弱。至於全年,我的預估是持平到低個位數成長。

  • Daniel Rizzo - Analyst

    Daniel Rizzo - Analyst

  • And then you kind of talked about not doing any divestitures or acquisitions in the last two years. I was wondering -- I mean, obviously, your focus is on organic and internal growth, but I was wondering if that's kind of what we should expect going forward. I mean, there's not a lot out there. We're focusing on our business. What are thoughts out there?

    另外你也提到過去兩年沒有做任何資產剝離或併購。我想問——我的意思是,很明顯你們的重點在有機成長與內生成長,但我想知道未來是否也會是我們應該預期的方向。也就是說,外面可買的標的並不多。我們專注在自己的業務。你們對外部機會的想法是什麼?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • So one of the things that we are trying to do, Laurence (sic - Dan), is build a few muscles of innovation and commercialization. And that has been going well for the last two years. You can see the teams getting better every day with customer focus and key account management and then innovating from the market inside. And then understanding the value chains in these growth vectors, which some of them are quite new to us is very important.

    所以我們正在嘗試做的一件事,Laurence(口誤—Dan),是建立幾項「肌肉」:創新與商業化能力。而這在過去兩年進展得很不錯。你可以看到團隊每天都在變得更好:更以客戶為中心、強化關鍵客戶管理,並且從市場端向內推動創新。此外,理解這些成長向量中的價值鏈也非常重要,其中有些對我們來說相當新。

  • So before we put in any acquisitions, which we think at some point, we will do, probably not this year, maybe something after that when we also have a better balance sheet situation than where we are today. But by that time, we expect to understand the value chains in our growth areas much better. And then M&A would probably be something to complement or augment our strategy of organic growth versus stand-alone M&A in a brand-new area.

    因此,在我們進行任何併購之前——我們認為在某個時間點會做,但可能不是今年,也許要等之後,且屆時我們的資產負債表狀況也會比現在更好。到那時,我們預期能更深入理解我們成長領域的價值鏈。然後併購很可能會是用來補強或擴大我們的有機成長策略,而不是在一個全新的領域做單獨的併購。

  • Operator

    Operator

  • Frank Mitsch, Fermium Research.

    Frank Mitsch,Fermium Research。

  • Frank Mitsch - Analyst

    Frank Mitsch - Analyst

  • Nice end to the year. If I could just follow up on that last question. It looks like you ended the year at a better net debt to EBITDA than perhaps was considered at the beginning of the year. And so you offered your thoughts, Ashish, on M&A. I'm curious as to what your thoughts are with respect to debt paydown versus buybacks.

    年底收得不錯。如果我可以就上一個問題追問一下。看起來你們年底的淨負債對 EBITDA 比率,比年初可能預期的更好。所以你已經分享了你對併購的看法,Ashish。我想了解你對於償還債務與庫藏股回購之間取捨的想法。

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes. So thanks, Frank. One of the things that we have obviously been prioritizing is paying down the debt, as you mentioned. I think, as I said, the next 12 months, no M&A. So most of the cash probably will still go on paying towards more debt.

    是的。謝謝你,Frank。如你所提到的,我們顯然一直把償還債務作為優先事項。我想,正如我說的,接下來 12 個月不會做併購。因此,大部分現金可能仍會用於進一步償債。

  • We would like to make that situation stronger than -- so we expect to finish the year lower than 2.5x for sure, if not better than that. And I think that at that point, we'll have more flexibility of buyback versus debt reduction situation and also looking at M&A at that point in time would make sense. But I would say that in the near term, you can expect us to keep paying the debt versus buyback. That would be my strategy on deployment of the cash.

    我們希望把這個狀況再強化——所以我們預期年底一定會低於 2.5 倍,甚至可能更好。我認為到那個時點,我們在回購與降債之間會有更大的彈性,而在那個時間點再來看併購也會更合理。但我會說,短期內你可以預期我們會持續償債,而不是回購。這會是我對現金運用的策略。

  • Frank Mitsch - Analyst

    Frank Mitsch - Analyst

  • Okay. Understood. Understood. I appreciate the color with respect to the patent filings. I'm curious if we could ask it another way in terms of a vitality index in terms of products introduced over the last four or five years and how you track that and where that stands today.

    好的。了解。了解。我很感謝你提供關於專利申請的補充說明。我想換個方式問:以活力指數(vitality index)的角度,看看過去四到五年推出的產品占比,你們如何追蹤,以及目前大概處於什麼水準?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • So I do track that internally, Frank, but for me, that number is not as critical. And I come from a company, as you know, where these vitality index were talked about a lot. I think it's a good internal measure for us to keep tracking to see the health of the organization and the creativity of the organization is in play. But for me, it's really -- you could have a couple of products that are big and are creating a lot of value. And so I think for us, it's more important what is creating growth. And obviously, we have to do a lot of product development for replacement because the market needs that.

    Frank,我內部確實有追蹤這個指標,但對我來說,那個數字沒有那麼關鍵。而且如你所知,我來自一家很常談活力指數的公司。我認為這是個不錯的內部衡量方式,讓我們持續追蹤,以觀察組織的健康度以及組織創造力是否在發揮。但對我而言,重點其實是——你可能只有幾個很大的產品,就能創造很多價值。所以我認為對我們來說,更重要的是什麼在創造成長。當然,我們也必須做大量的產品開發來因應汰換需求,因為市場需要。

  • But really, as we are bringing our strategy into this growth mode through growth vectors, especially in these new areas, I think the focus is to net new growth creation for us. That's how we measure it. Our NPVI, or new product vitality index, is pretty healthy. It's internally, but I don't intend to speak about it. But the difference is that most of that NPVI has been based on replacement products versus products that create new growth.

    但真正地,當我們透過成長向量把策略帶入這種成長模式,特別是在這些新領域時,我認為重點是為我們創造「淨新增」的成長。我們就是這樣衡量的。我們的 NPVI(新產品活力指數)相當健康。這是內部指標,但我不打算對外談它。不過差異在於:過去大部分 NPVI 主要來自汰換型產品,而不是能創造新成長的產品。

  • And I'm trying to flip that around and say, okay, we need products that the customers need replacement on an ongoing basis, which is a very important part of our core business. But we now need to also create products which are going to create brand-new growth for this company. And that's what some of the products I keep highlighting in some of our slides. These products did not exist a couple of years ago, and they're creating brand-new growth for us.

    而我正試著把它反過來:好,我們需要客戶持續有汰換需求的產品,這是我們核心業務非常重要的一部分。但我們現在也需要創造能為這家公司帶來全新成長的產品。這也是我在一些投影片中持續強調的部分產品。這些產品在幾年前並不存在,而它們正在為我們創造全新的成長。

  • Frank Mitsch - Analyst

    Frank Mitsch - Analyst

  • That's very helpful. I'm looking forward to any other metrics that you might be able to catch that transformation from replacement versus new growth down the line, so we get a better handle on it.

    這非常有幫助。我也期待未來你們若能捕捉到其他指標,能夠反映「替換」相對於「新增成長」之間的轉變,讓我們能更好地掌握情況。

  • Operator

    Operator

  • Aleksey Yefremov, KeyBanc Capital Markets.

    Aleksey Yefremov,KeyBanc Capital Markets。

  • Unidentified Participant

    Unidentified Participant

  • This is Brian on for Aleksey. I just wanted to go back. I think you guys talked about some more productivity gains and maybe some cost cuts. I think there's some carryover from '25, but you guys also mentioned some new actions. So maybe if you could kind of help us understand in terms of dollar-wise, how much is embedded in the guide for this year? How much is carryover from '25? And how much are these new actions? And what exactly are these actions that you guys are taking?

    我是 Brian,代 Aleksey 發言。我想回到剛才的話題。我記得你們談到一些進一步的生產力提升,可能也有一些成本削減。我想其中有一部分會從 25 年延續過來,但你們也提到一些新的行動。所以也許你們可以幫我們用金額的角度理解:今年指引中包含了多少?有多少是從 25 年延續的?又有多少是這些新的行動?以及你們正在採取的行動具體是什麼?

  • Jamie Beggs - Chief Financial Officer, Senior Vice President

    Jamie Beggs - Chief Financial Officer, Senior Vice President

  • Brian, thanks for the question. Our productivity initiatives really center around four to five major programs. That includes sourcing savings, taking a look at our footprint and optimizing it, Lean Six Sigma programs as well as simplifying our structure. And so we accomplished a little over $40 million of net productivity from last year. We expect about half of that to basically continue on into 2026 based on when those actions were initiated. And as we take a look at guidance for the full year for 2026, it really is a lever that we will continue to take a look at depending on demand will need to go.

    Brian,謝謝你的提問。我們的生產力計畫主要聚焦在四到五個大型專案。包括採購節省、檢視並最佳化我們的據點布局、精實六標準差(Lean Six Sigma)專案,以及簡化組織架構。因此,我們去年達成了略高於 4,000 萬美元的淨生產力效益。我們預期其中約一半會在 2026 年延續,取決於這些行動啟動的時間點。而在我們對 2026 全年指引的檢視中,這確實是一個我們會持續評估的槓桿,並視需求走向而定。

  • We're a big believer that we need to invest in the underlying growth of the business. And so you want to be a little bit cautious about cutting too deep on certain things. And so as we look at how demand evolves, we'll take a look at that productivity initiatives. But like we said in the commentary earlier today, we really are taking a harder look at how demand will end up playing out. Our net inflation for the year is around $30 million. So that's at a baseline. There could be more depending on how the year evolves.

    我們非常相信必須投資於業務的底層成長。因此,在某些項目上削減得太深需要更謹慎。所以,隨著需求的演變,我們會再檢視這些生產力計畫。但正如我們今天稍早在評論中所說,我們確實正在更嚴格地檢視需求最終會如何發展。我們今年的淨通膨約為 3,000 萬美元。這是基準情境。視今年的發展情況,可能還會更多。

  • Unidentified Participant

    Unidentified Participant

  • Okay. Great. That's very helpful. And then I just wanted to ask, in terms of the kind of regional performance, I mean, Asia obviously stands out, right? It's the only region that grew organically in the fourth quarter. So I just want to understand maybe what's driving that. Is that largely the exposure you have kind of on the semi front in packaging? Or is it something else?

    好的。很好。這非常有幫助。接著我想問一下,就區域表現而言,亞洲顯然很突出,對吧?它是第四季唯一有機成長的地區。所以我想了解是什麼在驅動。這主要是你們在半導體端、封裝方面的曝險所帶動嗎?還是其他因素?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes. So Asia has been -- actually, Q4 has been a good story because Q3 Asia was negative 1% for us. And Q4, we flipped it positive and plus 3%. And that's largely coming from GCA, which also flipped from minus 1% to plus 4.5%. And if you look into GCA, both packaging went in the right direction. I just visited our Asia team in January. I was there, and I was very pleasantly surprised to see how much market share they are gaining in a market that is not growing, especially in the food and beverage area.

    是的。所以亞洲其實——第四季是一個很好的故事,因為第三季我們在亞洲是負 1%。而第四季我們翻正到正 3%。這主要來自 GCA,也從負 1%翻正到正 4.5%。如果你深入看 GCA,封裝兩個面向都朝正確方向發展。我一月剛拜訪我們的亞洲團隊。我人在那裡,非常驚喜地看到他們在一個不成長的市場中仍大幅提升市占,尤其是在食品與飲料領域。

  • And so that brought us pretty healthy on the packaging side from negative to slightly positive in GCA, which helped a lot because packaging is the biggest market there. It's about 33% of GCA.

    因此,這讓我們在 GCA 的封裝業務表現相當健康,從負轉為略為正成長,幫助很大,因為封裝是那邊最大的市場。它約占 GCA 的 33%。

  • And then the other part is that in high-performance computing, which Jamie mentioned in her remarks, we have been growing quite well in that secular trend and materials that are used in semiconductor chip packaging and wafer packaging have been growing at double digits for us, which was also the case in Q4, which really helped Asia as well. So those were the two main reasons.

    另外一部分是在高效能運算方面,正如 Jamie 在發言中提到的,我們在這個長期趨勢中成長得相當不錯;用於半導體晶片封裝與晶圓封裝的材料對我們而言一直是雙位數成長,第四季也是如此,這也確實幫助了亞洲。所以這是兩個主要原因。

  • Operator

    Operator

  • Kristen Owen, Oppenheimer & Company.

    Kristen Owen,Oppenheimer & Company。

  • Kristen Owen - Analyst

    Kristen Owen - Analyst

  • I wanted to pick up the thread, Jamie, on the EBITDA margin expansion. You guys have done a really nice job of continuing to grow that margin in a tough environment. But as we look back to, say, 2024 Investor Day, you had this target out there of 20% EBITDA. If we were to revisit that target against the work that you've done on productivity since those targets were laid out, how do you think about the buckets of opportunity that you have to move further towards that 20% EBITDA margin target?

    Jamie,我想延續一下 EBITDA 利潤率擴張的話題。在艱難的環境下,你們持續把利潤率做上去,表現得非常好。但如果回頭看,例如 2024 年投資人日,你們提出了 20% EBITDA 的目標。若把這個目標與你們自提出目標以來在生產力方面所做的工作對照來看,你們如何看待還有哪些機會領域(bucket of opportunity),可以進一步朝 20% EBITDA 利潤率目標邁進?

  • Jamie Beggs - Chief Financial Officer, Senior Vice President

    Jamie Beggs - Chief Financial Officer, Senior Vice President

  • Thanks for the question, Kristen. So when we laid out in the Investor Day, we were sitting around a little over 16% EBITDA margins. Our goal is to get above 20% EBITDA margins. And how we looked at how that would evolve over time would be about half of it be related to operating leverage, another quarter of that related to moving up the value chain in terms of mix, and then also another quarter from productivity.

    謝謝你的提問,Kristen。我們在投資人日提出時,EBITDA 利潤率大約在 16%多一點。我們的目標是把 EBITDA 利潤率提升到 20%以上。而我們當時對其隨時間演進的看法是:大約一半來自營運槓桿,另外四分之一來自產品組合往價值鏈上移(mix 改善),再另外四分之一來自生產力。

  • Obviously, the last couple of years has been more focused on the mix dynamic and the productivity dynamic. And in fact, if you take a look at the 50 basis points of expansion that we accomplished in 2025, there wasn't any operating leverage just based on -- as you can see, our organic sales were basically flat for the year. But we did have quite a bit of price mix and productivity, I would say, about half and half between those two.

    很明顯,過去幾年更聚焦在組合動態與生產力動態。事實上,如果你看我們在 2025 年達成的 50 個基點擴張,基本上沒有任何營運槓桿——因為如你所見,我們全年有機銷售幾乎持平。但我們確實有相當多的價格/組合與生產力貢獻,我會說這兩者大約各占一半。

  • So as we look forward and we look at the opportunity to continue to expand margin, obviously, price/mix will to be a lever. We are very focused on productivity, especially in, I would say, a low demand environment. And I think you're going to see a pretty big uplift once the market starts to, I would say, stabilize in some of our core markets such as consumer and building construction and industrial. I think that would really boost that up. But as I look forward to 2026, I think the majority of it at this juncture, we're counting on the expansion coming from those two other areas.

    所以展望未來,當我們看持續擴大利潤率的機會時,顯然價格/組合會是一個槓桿。我們也非常專注於生產力,尤其是在我會說需求偏低的環境下。而我認為一旦市場開始——我會說——在我們一些核心市場(例如消費、建築施工與工業)趨於穩定,你會看到相當明顯的提升。我認為那會把它大幅推升。但就我對 2026 年的看法,在目前這個時間點,我們主要是仰賴另外兩個領域帶來的擴張。

  • Kristen Owen - Analyst

    Kristen Owen - Analyst

  • That's super helpful. And maybe double-clicking on sort of that macro piece. What catalyzes Color here? You've talked about some of the big macro pieces. But is there anything from a portfolio standpoint, things like maybe the PFAS replacement products that we should be thinking about sort of driving that market outgrowth in Color going forward?

    這非常有幫助。也許再更深入一點談談總體環境那一塊。在這裡,Color 的催化因素是什麼?你們談過一些重大的總體因素。但從產品組合角度來看,有沒有什麼——例如 PFAS 替代產品——是我們應該思考、未來可能推動 Color 市場超越大盤成長的因素?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes, Kristen, I think the big opportunities for Color are in the area of functional additives and PFAS is one example of that, but same things can be extended to certain kinds of flame retardants, also can be extended into foaming agents, which are used in building and construction materials. And all those things are -- that functional additives is about close to $0.5 billion business for us. So it's sizable in Color. It's not insignificant. And if we can grow that fast based on, again, adapting to some of these secular trends and our growth vectors, we feel that we have a good story, and that's what we are pursuing.

    是的,Kristen,我認為 Color 的重大機會在於功能性添加劑領域,PFAS 就是一個例子;同樣的概念也可以延伸到某些類型的阻燃劑,也可以延伸到發泡劑(用於建築與施工材料)。而所有這些——功能性添加劑對我們而言大約是接近 5 億美元的業務。所以在 Color 裡規模不小。並非微不足道。而如果我們能夠基於再次適應這些長期趨勢與我們的成長向量來快速成長,我們認為我們有一個很好的故事,而這正是我們正在推進的方向。

  • Kristen Owen - Analyst

    Kristen Owen - Analyst

  • Great. And if you don't mind, if I could sneak one more in, just double-click on the defense investment. Like are you currently demand constrained and that's what's driving the additional CapEx? That's my last question.

    很好。如果你不介意的話,我想再插問一個,深入追問一下國防投資。例如你們目前是否受到需求限制,而這就是推動額外資本支出(CapEx)的原因?這是我最後一個問題。

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • No, I think we are not demand constrained, and we are driving as much as we can. Obviously, this business is lumpy and sometimes shifts between quarters as we have highlighted several times before. But defense has grown double digits, 14% in 2024 and 8% in 2025. We again expect a strong year from this business, continue to see strength there and actually are making capacity investments, innovation for -- debottlenecking the capacity right now, as we highlighted today in one of the examples, which is already underway and then making some more CapEx investments that Jamie mentioned for $33 million, which will bring additional capacity in 2028.

    不,我認為我們並沒有受到需求限制,我們正在盡可能推動成長。顯然,這項業務具有波動性,有時會在季度之間移轉,我們之前也多次強調過。但國防業務已經以雙位數成長,2024 年成長 14%,2025 年成長 8%。我們再次預期這項業務今年會很強勁,持續看到其強勢,並且實際上正在進行產能投資與創新——目前正在進行產能去瓶頸,我們今天在其中一個例子中也提到,這已經在進行中;同時也會進一步進行 Jamie 提到的 3,300 萬美元資本支出投資,將在 2028 年帶來額外產能。

  • So this business takes a while because it's very process intensive and needs a lot of equipment. And so it does take time. So when we look into the future, we still see this business growing quite well over the next several years. And so we are making investment decisions now so that we are ready when the capacity continues to grow.

    所以這項業務需要一些時間,因為它非常依賴製程,且需要大量設備。因此確實需要時間。所以當我們展望未來時,我們仍然看到這項業務在未來幾年會成長得相當不錯。因此我們現在就做出投資決策,確保當產能需求持續成長時,我們已經準備就緒。

  • Operator

    Operator

  • Mike Harrison, Seaport Research Partners.

    Mike Harrison,Seaport Research Partners。

  • Michael Harrison - Analyst

    Michael Harrison - Analyst

  • Congrats on a nice finish to the year. I was hoping just to ask another question there on the Dyneema process that you talked about and some of the changes you're making there. Can you give some more color on what exactly you're changing?

    恭喜今年收官表現不錯。我想再問一個關於你提到的 Dyneema 製程以及你們正在做的一些變更的問題。你能否更具體說明你們到底在改變什麼?

  • You kind of categorized it as a debottlenecking, but it also sounds like you've added some additional capabilities to really tailor some of those products to specific customer requirements or specific applications. And then beyond that, are you able to share how much additional capacity you're going to be able to get as a result of that change? And also, what does that mean for the margin performance of that Dyneema business just from the debottlenecking and changes that you're making to process [merger]?

    你把它歸類為去瓶頸,但聽起來你們也新增了一些額外能力,能更貼合某些產品以符合特定客戶需求或特定應用。此外,你們是否能分享,因為這項變更你們能增加多少額外產能?另外,僅就去瓶頸以及你們對製程所做的變更而言,這對 Dyneema 業務的毛利表現意味著什麼[merger]?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes, there's many questions there, Mike. And I'll probably start with saying that I cannot disclose anything about the process. It's a trade secret because we don't -- in process innovation, it's very hard to file and then police patents. So I just kept trade secrets as pretty standard, and that's what we have done here as well. So all I can tell you is that the whole idea is you have to make -- these fibers are made at a certain tenacity, which gives the strength to the fiber and that tenacity value is achieved. The slower you spin the fiber, the more crystallization can happen to the fiber, which can give it higher tenacity and so on and so forth.

    是的,Mike,你問了很多問題。我可能先說,我無法披露任何關於製程的細節。這是商業機密,因為——在製程創新方面,很難申請專利,之後也很難執行與維權。所以我一向把它作為商業機密處理,這是相當標準的做法,我們這次也是如此。所以我能告訴你的只有整體概念:這些纖維是在某個特定的強度(tenacity)下製造的,這個強度賦予纖維其強韌度,而這個強度值需要被達成。你纖維紡絲得越慢,纖維就越可能發生更多結晶,從而帶來更高的強度,依此類推。

  • So typically, when you make high-performance fibers, you're slowing down your speed of the equipment significantly if you want to increase tenacity. And I think our teams have figured out ways how to not slow it down and continue to ramp it up at a fast rate. So I think that's as much as I can tell on the process innovation side.

    因此通常在製造高性能纖維時,如果你想提高強度,就必須大幅降低設備速度。而我認為我們的團隊已經找到了方法,在不降低速度的情況下,仍能以很快的速率持續拉升產出。所以在製程創新方面,我大概只能說到這裡。

  • It is a slight modification of the equipment, but also process modification, and the team has worked on it diligently for more than a year to get us here. So it's significant. It does give us enough capacity to buy time until 2028 when our new capacity would be needed.

    這涉及對設備的些微改造,也包括製程的調整,而團隊為了達到目前成果,已經勤奮投入超過一年。所以這是重大的。它確實能給我們足夠的產能,讓我們爭取時間,直到 2028 年我們的新產能才會需要上線。

  • And I think clearly, we were not expecting defense to grow like it has been growing. We were thinking more like mid-single digit kind of growth, and it has been growing double digits or high single digits. So this debottlenecking is really helping us get there without compromising and without not being able to serve our customers on time, while in the meantime, we are making these new investments so that we are ready and also when we run out of capacity.

    而且我想很明顯地,我們原本並不預期國防業務會以目前這樣的速度成長。我們原先預期大概是中個位數成長,但實際上一直是雙位數或高個位數成長。因此,這次去瓶頸確實幫助我們在不犧牲、不影響準時服務客戶的情況下達成目標;同時,我們也在進行這些新的投資,確保我們準備就緒,並且在我們產能用盡時也能接續上。

  • Michael Harrison - Analyst

    Michael Harrison - Analyst

  • All right. That's helpful. And then on the health care business, I'm just curious, a number of these GLP-1 drugs appear to be shifting from a weekly injection with an injector pen that I think you guys are involved with to either a monthly injection or even an oral dosage. So can you just talk a little bit about your drug delivery product line within health care and whether you expect to see any impact from kind of the evolution of how those GLP-1 drugs are administered?

    好的。這很有幫助。接著關於醫療保健業務,我有點好奇:一些 GLP-1 藥物似乎正從每週一次、使用注射筆(我想你們有參與)轉向每月一次注射,甚至是口服劑型。所以你能否談談你們在醫療保健中的藥物遞送產品線,以及你們是否預期會因 GLP-1 藥物給藥方式的演進而受到任何影響?

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes. So drug delivery for us is a couple of things. What you mentioned on GLP pens and that's one part of it. The other part of it is basically things that are remote devices, which are used for delivering drugs and glucose monitoring and so on and so forth. That's also part of health care.

    是的。所以對我們而言,藥物遞送包含幾個部分。你提到的 GLP 注射筆是一部分。另一部分基本上是遠端裝置,用於藥物遞送、血糖監測等等。那也屬於醫療保健的一部分。

  • But just from a GLP perspective, it's too early for us to say that -- we believe, and our customers believe, that there is a market for both oral and injector pens at this point in time. The injectors are also being utilized for other applications, not just for weight reduction.

    但就 GLP 的角度而言,現在對我們來說還太早下結論——我們相信,我們的客戶也相信,目前口服與注射筆兩種形式都有市場。而注射器也被用於其他應用,不僅僅是用於減重。

  • And so the market overall growth is expanding and is continued to be robust. That's the signal we get from our customers. And so we are going with that premise at this point in time. And both in drug delivery devices, remote monitoring devices, as well as injector pen kind of devices, we seem to be doing quite well and expect that to continue at least for 2026.

    因此整體市場的成長正在擴大,並且仍然強勁。這是我們從客戶那裡得到的訊號。所以目前我們是以這個前提來推進。而在藥物遞送裝置、遠端監測裝置,以及注射筆類裝置方面,我們看起來都做得相當不錯,並預期至少在 2026 年會持續如此。

  • Operator

    Operator

  • David Begleiter, Deutsche Bank.

    David Begleiter,德意志銀行(Deutsche Bank)。

  • Emily Fusco - Analyst

    Emily Fusco - Analyst

  • This is Emily Fusco on for Dave Begleiter. What are your expectations for pricing in CAI and Specialty for 2026?

    我是 Emily Fusco,代 Dave Begleiter 提問。你們對 2026 年 CAI 與 Specialty 的定價有何預期?

  • Jamie Beggs - Chief Financial Officer, Senior Vice President

    Jamie Beggs - Chief Financial Officer, Senior Vice President

  • So Emily, when we think about pricing, we're obviously always doing value pricing. And so when we take a look at -- we take a look at both price and mix as we move forward. And as we've mentioned from what occurred back in 2025, we've had a lot of success in health care and in defense. That has driven a lot of our price/mix dynamic in '25. We expect that to continue as we think about 2026.

    所以,Emily,當我們談到定價時,我們顯然一直都在做價值定價。因此,當我們往前看時——我們會同時檢視價格與組合(mix)。而且如同我們提到的,從2025年發生的情況來看,我們在醫療保健與國防領域取得了很大的成功。這在2025年推動了我們大量的價格/組合動態。我們預期在思考2026年時,這種趨勢會持續。

  • Other pricing initiatives that people think about as what's going on with the raw materials. We've proven through, I would say, at least the five years, six years that I've been here that that doesn't really seem -- it could enable us to be able to capture some margin expansion. We always are on top of it in terms of making sure that it's not destructed the margin based on where raw materials are.

    另外一些人會關注的定價舉措,是原材料方面正在發生什麼。我想說,至少在我在這裡的五年、六年期間,我們已經證明那其實並不太——它可能讓我們能夠捕捉到一些利潤率擴張。我們一直都會密切掌握,確保原材料所在的水準不會侵蝕利潤率。

  • So in our bridges, we just normally -- like I mentioned with Kristen's comment, we do expect some margin expansion in 2026 based on price mix, and that really is a function of where we're selling our products, not because there's specific pricing initiatives going on other than our normal monitoring of where raw materials are and making sure that we're value pricing our products as they're created and differentiated from what is else in the market.

    所以在我們的橋接(bridge)分析中,我們通常——就像我在回應Kristen的評論時提到的,我們確實預期2026年會因價格與組合而有一些利潤率擴張;而那其實取決於我們把產品賣到哪裡,而不是因為除了我們一貫監控原材料走勢、並確保在產品被開發並與市場上其他產品形成差異化時採取價值定價之外,還有什麼特定的定價舉措正在進行。

  • Operator

    Operator

  • Ghansham Panjabi, Robert W. Baird.

    Ghansham Panjabi,Robert W. Baird。

  • Ghansham Panjabi - Senior Research Analyst

    Ghansham Panjabi - Senior Research Analyst

  • Ashish, just going back to the fourth quarter as it relates to the strategic growth vectors you've outlined in the past and so on and so forth, how did that portion of the portfolio grow on a core sales basis in the fourth quarter relative to where you came in on a consolidated basis, which was roughly down 1%?

    Ashish,回到第四季,關於你們過去所概述的策略性成長向量等,該部分投資組合在第四季以核心銷售(core sales)口徑的成長,相較於你們合併口徑約下滑1%的表現,成長情況如何?

  • Giuseppe Di Salvo - Vice President, Treasurer, Investor Relations

    Giuseppe Di Salvo - Vice President, Treasurer, Investor Relations

  • Growth vector growth versus the rest of the portfolio --

    成長向量的成長相較於投資組合其餘部分--

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • In fourth quarter specifically?

    是特別指第四季嗎?

  • Ghansham Panjabi - Senior Research Analyst

    Ghansham Panjabi - Senior Research Analyst

  • Yes -- or you give it to us for the year.

    是——或者你也可以給我們全年數字。

  • Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

    Ashish Khandpur - Chairman of the Board, President, Chief Executive Officer

  • Yes, for the year, maybe it's better for me to talk about the year versus quarter because these growth vectors are launched in different parts of the year. So it's kind of an unfavorable -- so as I mentioned, growth vectors grew high single digits for us. And high single digits for growth vectors versus less than 1% or low single-digit kind of decline in the rest of the business.

    是的,就全年來看,或許我談全年會比談單一季度更合適,因為這些成長向量是在一年中不同時間點推出的。所以這有點不利於——因此如我所提到的,成長向量對我們而言是高個位數成長。而成長向量的高個位數成長,相較之下,其他業務則是不到1%或低個位數的下滑。

  • Ghansham Panjabi - Senior Research Analyst

    Ghansham Panjabi - Senior Research Analyst

  • Okay. And then as it relates to core sales for the following year for 2026, did you break that out by segment? I'm not sure if I heard that.

    了解。那接著關於2026年下一年度的核心銷售,你們有按事業部門(segment)拆分嗎?我不確定我是否有聽到。

  • Jamie Beggs - Chief Financial Officer, Senior Vice President

    Jamie Beggs - Chief Financial Officer, Senior Vice President

  • No, we did not provide any specific guidance based on segments. We did provide a full-year range on EBITDA as well as EPS. We gave a little bit of color between the segments in terms of some of the end markets and where we're seeing weaknesses. Maybe just to reiterate, from an SEM perspective as well as from a Color perspective, we do expect things like health care to continue to perform well. SEM also has exposure to defense, which is also something that we continue to take a look at. And we are looking to see how the evolution really comes about for consumer, industrial, and building and construction, which will be a key driver for the Color segment.

    沒有,我們沒有按事業部門提供任何具體指引。我們提供了全年EBITDA以及EPS的區間。我們也就各事業部門的一些終端市場,以及我們看到的疲弱之處,提供了一點補充說明。也許再重申一次,從SEM的角度以及從Color的角度來看,我們確實預期像醫療保健這類領域會持續表現良好。SEM也有國防曝險,這也是我們持續關注的項目。而我們也在觀察消費、工業,以及建築與營建的演變將如何發展,這將是Color事業部門的關鍵驅動因素。

  • Operator

    Operator

  • Vincent Andrews, Morgan Stanley.

    Vincent Andrews,Morgan Stanley。

  • Turner Hinrichs - Analyst

    Turner Hinrichs - Analyst

  • This is Turner Hinrichs on for Vincent. I was just wondering if you could provide a little bit more regional color on what your 2026 guide considers for growth by region, particularly in Europe and Asia, considering you all have talked a lot about growth drivers in the US economy so far.

    我是Turner Hinrichs,代Vincent提問。我想請問,你們是否可以就2026年指引中各地區的成長假設提供更多區域面的補充說明,特別是歐洲與亞洲;因為到目前為止,你們談了很多美國經濟的成長驅動因素。

  • Jamie Beggs - Chief Financial Officer, Senior Vice President

    Jamie Beggs - Chief Financial Officer, Senior Vice President

  • So Turner, we didn't give any specific guidance just like the question that Ghansham said based on segments, but really we're talking more about from an end market perspective. Obviously, there's a lot of geopolitical uncertainty, trade tariffs, and other things going on as it impacts the US in particular. And so those are the things that we're watching closely as well as whether or not the Fed will decrease rates and at what pace will they actually do that.

    所以Turner,我們沒有提供任何具體指引——就像Ghansham剛才問的那樣——按事業部門拆分;我們主要是從終端市場的角度來談。顯然,地緣政治不確定性、貿易關稅以及其他因素很多,特別是對美國的影響。因此,這些都是我們密切關注的事項,同時也包括聯準會是否會降息,以及實際降息的速度會是如何。

  • I know you mentioned Europe and Asia specifically. As you can see from what happened in 2025 in Europe, we ended it down 1%. At this juncture, we're expecting similar levels until we see some type of potential recovery in the Asia dynamic. As Ashish also mentioned during the commentary, we are seeing some really nice tailwinds in our packaging space, our telecommunications space. And we expect with the underlying GDP there, although maybe slightly lower than what it's been previously, it's still a growth part of the world. So I would expect to continue to see growth in that area.

    我知道你特別提到歐洲與亞洲。從2025年歐洲的情況你也看得到,我們全年以-1%作收。在目前這個時間點,在我們看到亞洲動態可能出現某種復甦之前,我們預期會維持類似水準。另外如Ashish在評論中也提到,我們在包裝領域、電信領域看到相當不錯的順風。而且我們預期在當地的基礎GDP之下,雖然可能略低於先前水準,但那仍是全球中屬於成長的一個區域。因此,我預期那個區域的成長仍會持續。

  • Operator

    Operator

  • Thank you. This concludes the question-and-answer session. You may now disconnect. Everyone, have a great day.

    謝謝。問答環節到此結束。您現在可以斷線。各位,祝您有美好的一天。